Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes
- PMID: 7712708
- DOI: 10.1111/j.1464-5491.1995.tb02065.x
Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes
Abstract
Type 2 diabetes is characterized by resistance to insulin action of glucose metabolism and lipolysis. First-degree relatives of diabetic patients are at increased risk of developing diabetes themselves and early metabolic abnormalities in these relatives may represent primary defects in the pathogenesis of diabetes. Our previous work has demonstrated impaired suppression of lipolysis after an oral glucose load in glucose-tolerant relatives of Asian origin, but not in European relatives. To investigate whether a more subtle defect exists in the European population we studied 8 first-degree relatives of European patients and 9 matched control subjects. All had normal glucose tolerance. Glycerol and glucose turnovers were measured using a primed constant infusion of the stable isotopic tracers [1,1,1,2,3(2)H5] glycerol and [6,6(2)H] glucose, basally and in response to a very low dose insulin infusion (0.005 units kg-1 h-1). The relatives had higher basal insulin concentrations (median (range): 49 (30 to 113) vs 28 (18 to 66) pmol 1(-1), p < 0.05) compared to controls, but basal glycerol and glucose turnovers and plasma concentrations of glycerol, glucose, and non-esterifed fatty acids (NEFA) were similar. Following insulin, the suppression of glycerol appearance in the circulation measured isotopically was significantly less complete in the relatives compared with controls (mean change +/- SEM: + 0.06 +/- 0.21 vs - 0.51 +/- 0.16 mumol kg-1 min-1, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups.Clin Endocrinol (Oxf). 1994 Jan;40(1):55-62. doi: 10.1111/j.1365-2265.1994.tb02443.x. Clin Endocrinol (Oxf). 1994. PMID: 8306481
-
Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.Clin Endocrinol (Oxf). 1995 Mar;42(3):255-64. doi: 10.1111/j.1365-2265.1995.tb01873.x. Clin Endocrinol (Oxf). 1995. PMID: 7758230
-
Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?Diabetes. 1999 Aug;48(8):1572-8. doi: 10.2337/diabetes.48.8.1572. Diabetes. 1999. PMID: 10426375
-
Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus.Diabetologia. 1991 Mar;34(3):192-7. doi: 10.1007/BF00418275. Diabetologia. 1991. PMID: 1884892
-
Insulin resistance: a multifaceted metabolic syndrome. Insights gained using a low-dose insulin infusion technique.Diabet Med. 1996 Jan;13(1):30-9. doi: 10.1002/(SICI)1096-9136(199601)13:1<30::AID-DIA5>3.0.CO;2-I. Diabet Med. 1996. PMID: 8741810 Review.
Cited by
-
Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue.Diabetes. 2008 Sep;57(9):2272-9. doi: 10.2337/db08-0477. Epub 2008 Jun 2. Diabetes. 2008. PMID: 18519799 Free PMC article.
-
Improvement of glycemic control after a 3-5 day insulin infusion in type 2-diabetic patients with insulin resistance can be maintained with glitazone therapy.Wien Klin Wochenschr. 2006 Sep;118(17-18):543-8. doi: 10.1007/s00508-006-0656-4. Wien Klin Wochenschr. 2006. PMID: 17009067 Clinical Trial.
-
Mechanisms of Insulin Action and Insulin Resistance.Physiol Rev. 2018 Oct 1;98(4):2133-2223. doi: 10.1152/physrev.00063.2017. Physiol Rev. 2018. PMID: 30067154 Free PMC article. Review.
-
Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease.Oxid Med Cell Longev. 2019 Jan 17;2019:8165707. doi: 10.1155/2019/8165707. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 30800211 Free PMC article. Review.
-
Regulation of hepatic glucose metabolism in health and disease.Nat Rev Endocrinol. 2017 Oct;13(10):572-587. doi: 10.1038/nrendo.2017.80. Epub 2017 Jul 21. Nat Rev Endocrinol. 2017. PMID: 28731034 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous